VivoSeq
Dermatology

Scar Formation

0

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Scar Formation is an early-stage landscape with 0 programs across 1 company. The most active players are RXi Pharmaceuticals, Corp..

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

17/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

R

RXi Pharmaceuticals, Corp.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed4 · 67%
Terminated1 · 17%
Unknown status1 · 17%

Clinical Trials

Trial Activity

6 trials

Long Term Follow Up to Determine the Effects of Collagenase SANTYL Ointment on Scar Formation
Completed·HHealthpoint·N/A·NCT01705860·12 enrolled
Study of Trifarotene Cream to Assess Risk of a Trophic Acne Scar Formation
Completed·GGalderma R&D·Phase 4·NCT04856904·121 enrolled
Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109
Completed·RRXi Pharmaceuticals, Corp.·Phase 1·NCT01640912·15 enrolled
Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109
Completed·RRXi Pharmaceuticals, Corp.·Phase 1·NCT01780077·15 enrolled
Effect of Platelet Rich Plasma (PRP) on the Esthetic Outcome and Scar Formation of Unilateral Cleft Lip Repair
Terminated·—·Phase 2·NCT02958306·24 enrolled
Influence of a Silicone Gel (Dermatix®) on Thoracic Scar Formation After Harvesting of Autologous Rib Cartilage
Unknown status·UUniversity Hospital Schleswig-Holstein·N/A·NCT00565552·20 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)